Varian Medical Systems, Inc. Co (NYSE:VAR):
Grupo OncoclÃnicas Expands Treatment Capabilities with Varian Advanced Radiotherapy Equipment and Software.
The company is now up since yesterday’s close of $89.96.
Shares are trading at $90.09 barely below the 50 day moving average which is $96.83 and just above the 200 day moving average of $89.44. The 50 day moving average was down $-6.74 and the 200 day average went up $0.65 or +0.73%.
The company currently has a P/E ratio of 21.50 and the market cap of the company is 8.44B. In the last earnings report the EPS was $4.19 and is projected to be $4.97 for the current year with 93,699,000 shares currently outstanding. Next quarter’s EPS is forecasted at $1.18 and the next full year EPS is projected to be $5.46.
Investment analysts have released ratings on VAR of late. July 28 investment analysts at Jefferies kept the company rating at “Neutral” and moved up the price target to $88.00 from $85.00. On July 28 Citigroup held the company rating at “Buy” and raised the price expectation from $81.00 to $87.00.
On January 28 Jefferies left the stock rating at “Buy” and lowered the price target from $90.00 to $85.00. Equity analyst Barrington Research issued its first research report on the stock with an initial rating of “Outperform” and setting a price target of $91.00.
On December 22, 2015 RBC Capital released its first research report on the stock by announcing an initial rating of “Sector Perform” and a price target of $86.00. On November 12 analysts at Citigroup began coverage setting a rating of “Neutral” and projecting a price target of $81.00.